Literature DB >> 1329678

Detection of human papillomavirus in vulvar carcinoma. A study by in situ hybridisation.

A W Brandenberger1, R Rüdlinger, W Hänggi, N A Bersinger, E Dreher.   

Abstract

Fourty-four specimens of invasive cancers of the vulva, including 38 primary invasive squamous carcinomas, were analysed by in situ hybridisation with biotinylated HPV 6/11, 16 and 18 DNA probes. Four (9%) of the 44 carcinomas were positive for HPV DNA: three (7%) for HPV 16 DNA and one (2%) for HPV 6/11 DNA. HPV DNA was found only in squamous carcinomas. Of the 38 primary squamous carcinomas, 11% were positive (8% HPV 16, 3% HPV 6/11). The overall 5-year survival was 48.7%, 48.5% for the squamous carcinomas and 50.0% for the HPV DNA positive patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329678     DOI: 10.1007/bf02389604

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  15 in total

1.  High rate of human papillomavirus type 16 infection in cytologically normal cervices.

Authors:  J A Tidy; G C Parry; P Ward; D V Coleman; J Peto; A D Malcolm; P J Farrell
Journal:  Lancet       Date:  1989-02-25       Impact factor: 79.321

Review 2.  Human papillomaviruses and the polymerase chain reaction.

Authors: 
Journal:  Lancet       Date:  1989-05-13       Impact factor: 79.321

3.  Covalent binding of formalin fixed paraffin embedded brain tissue sections to glass slides suitable for in situ hybridization.

Authors:  W W Tourtellotte; A N Verity; P Schmid; S Martinez; P Shapshak
Journal:  J Virol Methods       Date:  1987-02       Impact factor: 2.014

4.  Papillomaviruses in human cancer.

Authors:  H zur Hausen
Journal:  Cancer       Date:  1987-05-15       Impact factor: 6.860

Review 5.  Human papillomaviruses and cancer.

Authors:  D J McCance
Journal:  Biochim Biophys Acta       Date:  1986

6.  Correlation of histology and detection of human papillomavirus DNA in vulvar cancers.

Authors:  G J Nuovo; P Delvenne; P MacConnell; E Chalas; C Neto; W J Mann
Journal:  Gynecol Oncol       Date:  1991-12       Impact factor: 5.482

7.  The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection.

Authors:  L S Young; I S Bevan; M A Johnson; P I Blomfield; T Bromidge; N J Maitland; C B Woodman
Journal:  BMJ       Date:  1989-01-07

8.  Human papillomavirus type 16/18 in uterine cervical adenocarcinoma in situ and adenocarcinoma. A study by in situ hybridization with biotinylated DNA probes.

Authors:  A L Nielsen
Journal:  Cancer       Date:  1990-06-01       Impact factor: 6.860

9.  The demonstration of human papillomavirus 16 genomes in the nuclei of genital cancers using two different methods of in situ hybridization.

Authors:  E I Grussendorf-Conen; S Cremer
Journal:  Cancer       Date:  1990-01-15       Impact factor: 6.860

10.  [Detection of human papilloma virus (HPV) DNA in vulvar cancers].

Authors:  H Ikenberg; D Schwörer; A Pfleiderer
Journal:  Geburtshilfe Frauenheilkd       Date:  1988-11       Impact factor: 2.915

View more
  2 in total

1.  Cell cycle suppressor proteins are not related to HPV status or clinical outcome in patients with vulvar carcinoma.

Authors:  André Mourão Lavorato-Rocha; Iara Sant'ana Rodrigues; Beatriz de Melo Maia; Mônica Maria Ágata Stiepcich; Glauco Baiocchi; Kátia Cândido Carvalho; Fernando Augusto Soares; José Vassallo; Rafael Malagoli Rocha
Journal:  Tumour Biol       Date:  2013-07-06

2.  Tumor proteomics by multivariate analysis on individual pathway data for characterization of vulvar cancer phenotypes.

Authors:  Annsofi Sandberg; Gunnel Lindell; Brita Nordström Källström; Rui Mamede Branca; Kristina Gemzell Danielsson; Mats Dahlberg; Barbro Larson; Jenny Forshed; Janne Lehtiö
Journal:  Mol Cell Proteomics       Date:  2012-04-12       Impact factor: 5.911

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.